Connection
Alok Singh to Double-Blind Method
This is a "connection" page, showing publications Alok Singh has written about Double-Blind Method.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.375 |
|
|
|
-
Singh A, Balasundaram MK. Comment on: "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention Deficit/Hyperactivity Disorder". CNS Drugs. 2022 12; 36(12):1331-1332.
Score: 0.132
-
Singh A, Balasundaram MK. Atogepant for Migraine Prevention: A Systematic Review of Efficacy and Safety. Clin Drug Investig. 2022 Apr; 42(4):301-308.
Score: 0.126
-
Singh A, Gupta D, Singh A. Ditans vs Gepants: A Systematic Review and Indirect Network Meta-Analysis for Comparative Analysis of Efficacy and Safety. Neurol India. 2021 Mar-Apr; 69(Supplement):S43-S50.
Score: 0.117